NCT06258616 Fluid Administration and Fluid Accumulation in the Intensive Care Unit
| NCT ID | NCT06258616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nordsjaellands Hospital |
| Condition | Fluid Accumulation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-04-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this international inception cohort study is to describe fluid administration during admittance to the intensive care unit (ICU), and provide contemporary epidemiological data on fluid accumulation, risk factors, management and outcome in critically ill adult patients.
Eligibility Criteria
Inclusion Criteria: * Acute admission to the ICU during the 14-day inception period. * Adults (≥ 18 years). Exclusion Criteria: * Patients previously included in the FLUID-ICU study. * Patients with major burns (≥ 10% of body surface)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06258616 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fluid Accumulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06258616 currently recruiting?
Yes, NCT06258616 is actively recruiting participants. Contact the research team at claramolinmolin@gmail.com for enrollment information.
Where is the NCT06258616 trial being conducted?
This trial is being conducted at Hillerød, Denmark, Aabenraa, Denmark, Aalborg, Denmark, Aarhus, Denmark and 11 additional locations.
Who is sponsoring the NCT06258616 clinical trial?
NCT06258616 is sponsored by Nordsjaellands Hospital. The trial plans to enroll 1,000 participants.